Specialist Medical Review Council Declaration: Statements of Principles Nos. 50 and 51 of 2017 concerning rheumatoid arthritis

Administered by Department of Veterans' Affairs

Legislation au C2018G00818 In force Gazette

Legislation content

Specialist Medical Review Council

Declarations

Section 196W
Veterans’ Entitlements Act 1986

 

Re: Specialist Medical Review Council’s review of the

decision of the Repatriation Medical Authority in respect to

Statements of Principles 50 and 51 of 2017 for rheumatoid arthritis.

 

Request for Review Declaration No. 35

 

  1. In relation to the RMA Statements of Principles Nos. 50 and 51 of 2017 concerning rheumatoid arthritis made under subsection 196B of the Veterans' Entitlements Act 1986 (the VEA), the Council under subsection 196W(5) of the VEA:

DECLARES that there is insufficient sound medical-scientific evidence on which the RMA could have relied to amend the Statements of Principles to include factor(s) for:

  • exposure to mineral oils containing PCBs or acute PCB exposure.

 

 

Lin Fritschi

Presiding Councillor

John Edwards

Councillor

Lyn March

Councillor

 

 

 

 

 

 

The Common Seal of the )
Specialist Medical Review ) Council was affixed by             )

authority of the Council in )

the presence of:  )

 

 

 

 

 

Jan Bowman

Registrar, SMRC

 

Dated this sixteenth  day of October 2018

 

 

 

 

Overview

The Veterans’ Entitlements Act 1986, enacted to provide comprehensive support and benefits for veterans, including medical and financial assistance, aims to address the specific needs of individuals who have served in the Australian Defence Force. The Specialist Medical Review Council was introduced to ensure that medical decisions regarding veterans' entitlements are thoroughly reviewed and based on sound medical-scientific evidence. This council operates under subsection 196W(5) of the VEA to review and provide declarations on the adequacy of medical evidence supporting the Repatriation Medical Authority’s decisions. The Specialist Medical Review Council Declaration No. 35 issued on 16 October 2018 addresses the inadequacy of evidence concerning exposure to mineral oils containing polychlorinated biphenyls (PCBs) or acute PCB exposure as factors in the Statements of Principles for rheumatoid arthritis. This declaration was made by the Council to ensure that any amendments to the Statements of Principles are backed by sufficient and reliable medical-scientific evidence, thereby protecting the rights and entitlements of veterans.

Scope and Application

The Specialist Medical Review Council Declarations Section 196W of the Veterans’ Entitlements Act 1986 applies to the Council's review of decisions made by the Repatriation Medical Authority (RMA) concerning Statements of Principles related to veterans' health conditions. Specifically, this declaration addresses the RMA's 2017 Statements of Principles Nos. 50 and 51 concerning rheumatoid arthritis. The Act applies to the Council as an entity responsible for conducting reviews and making declarations on the adequacy of medical-scientific evidence supporting RMA decisions. The scope of this Act is national, as it pertains to veterans' entitlements across Australia, thereby encompassing all states and territories within the Commonwealth. The Act does not specify exclusions or exemptions, though it operates within the confines of the evidence presented and the legal framework established by the VEA. The application of this Act may be extended or refined through subordinate instruments, such as regulations or guidelines, which may provide further detail on the review process and criteria for declarations.

Key Provisions

The Specialist Medical Review Council’s review, as outlined in Declaration No. 35, addresses the decision of the Repatriation Medical Authority (RMA) regarding Statements of Principles 50 and 51 of 2017 for rheumatoid arthritis (sections 196W, 196B). According to the Council’s declaration, there is insufficient sound medical-scientific evidence to support the inclusion of exposure to mineral oils containing polychlorinated biphenyls (PCBs) or acute PCB exposure as factors in the Statements of Principles. This decision was made under the authority of the Veterans' Entitlements Act 1986 (VEA) and signifies the Council's assessment of the medical evidence available at the time. The obligations imposed by this declaration on the parties governed by the VEA include the responsibility for the Specialist Medical Review Council to review and assess the medical evidence pertinent to the Statements of Principles. The RMA, in turn, is required to consider the Council's declaration in any future reviews or amendments of the Statements of Principles. Furthermore, the Council’s declaration must be communicated clearly to stakeholders, including veterans and their representatives, to ensure transparency and informed decision-making regarding veterans' entitlements. Under the VEA, breaches of the Council’s obligations to conduct thorough and evidence-based reviews, or the RMA's failure to adhere to the Council’s declarations, could result in legal consequences. Although the specific offences, penalties, or consequences for such breaches are not detailed within this particular declaration, the VEA generally provides for enforcement measures which could include administrative sanctions, judicial review, or other civil remedies. The maximum penalties for non-compliance could vary, depending on the nature and severity of the breach, but could potentially include fines or other punitive measures as prescribed by the Act.

Legal classification tags

Area of Law
Medical Law
Instrument
Gazette Notice
Concepts
Definitions & Interpretation
Offence Provisions
Regulatory Standards
Catchwords
medical-scientific evidence

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.